Literature DB >> 19665092

Clostridium difficile infection in the intensive care unit.

David J Riddle1, Erik R Dubberke.   

Abstract

Clostridium difficile infection (CDI) is becoming more common worldwide. The morbidity and mortality associated with C difficile is also increasing at an alarming rate. Critically ill patients are at particularly high risk for CDI because of the prevalence of multiple risk factors in this patient population. Treatment of C difficile continues to be a difficult problem in patients with severe or recurrent disease. This article seeks to provide a broad understanding of CDI in the intensive care unit, with special emphasis on risk factor identification, treatment options, and disease prevention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665092      PMCID: PMC2726831          DOI: 10.1016/j.idc.2009.04.011

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  135 in total

Review 1.  Clinical practice. Antibiotic-associated diarrhea.

Authors:  John G Bartlett
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

2.  Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; A Richard; K Hamadi; V Chomette; B Burghoffer; J C Petit
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 3.  Alternative treatments for Clostridium difficile disease: what really works?

Authors:  Lynne V McFarland
Journal:  J Med Microbiol       Date:  2005-02       Impact factor: 2.472

4.  Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.

Authors:  E M Grossmann; W E Longo; D L Kaminski; G S Smith; C E Murphy; R L Durham; M J Shapiro; J G Norman; J E Mazuski
Journal:  J Surg Res       Date:  2000-02       Impact factor: 2.192

5.  Intracolonic use of vancomycin for treatment of clostridium difficile colitis in a patient with a diverted colon: report of a case.

Authors:  D R Nathanson; M Sheahan; L Chao; M K Wallack
Journal:  Dis Colon Rectum       Date:  2001-12       Impact factor: 4.585

Review 6.  Epidemiology of Clostridium difficile-associated infections.

Authors:  F Barbut; J C Petit
Journal:  Clin Microbiol Infect       Date:  2001-08       Impact factor: 8.067

7.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

8.  Clostridium difficile toxins A and B directly stimulate human mast cells.

Authors:  Gesa K A Meyer; Anne Neetz; Gudrun Brandes; Dimitrios Tsikas; Joseph H Butterfield; Ingo Just; Ralf Gerhard
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

Review 9.  Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.

Authors:  R Nelson
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

Review 10.  Science review: The use of proton pump inhibitors for gastric acid suppression in critical illness.

Authors:  Stephen Brett
Journal:  Crit Care       Date:  2004-10-08       Impact factor: 9.097

View more
  15 in total

1.  Clostridium Difficile Colitis in Trauma Patients - a Global Step by Step Review.

Authors:  Silviu Morteanu; Georgiana Chirt; Mircea Beuran
Journal:  Maedica (Buchar)       Date:  2015-06

Review 2.  Nosocomial infections and multidrug-resistant bacterial organisms in the pediatric intensive care unit.

Authors:  Eric J McGrath; Basim I Asmar
Journal:  Indian J Pediatr       Date:  2010-10-09       Impact factor: 1.967

Review 3.  Current issues on safety of prokinetics in critically ill patients with feed intolerance.

Authors:  Nam Q Nguyen; Swee Lin Chen Yi Mei
Journal:  Ther Adv Drug Saf       Date:  2011-10

4.  Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies.

Authors:  Suresh Paudel; Ioannis M Zacharioudakis; Fainareti N Zervou; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

5.  Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit.

Authors:  Amer Custovic; Jasmina Smajlovic; Sadeta Hadzic; Sead Ahmetagic; Nijaz Tihic; Haris Hadzagic
Journal:  Mater Sociomed       Date:  2014-02-20

6.  Prevalence and Clinical Outcomes of Clostridium difficile Infection in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Authors:  Styliani Karanika; Suresh Paudel; Fainareti N Zervou; Christos Grigoras; Ioannis M Zacharioudakis; Eleftherios Mylonakis
Journal:  Open Forum Infect Dis       Date:  2015-12-01       Impact factor: 3.835

Review 7.  Clostridium difficile Infection in Special High-Risk Populations.

Authors:  Alberto Cózar-Llistó; Antonio Ramos-Martinez; Javier Cobo
Journal:  Infect Dis Ther       Date:  2016-08-11

8.  Antibiotic prophylaxis in organophosphorus poisoning: A study of health and economic outcomes.

Authors:  Asim Priyendu; K E Vandana; Muralidhar Varma; Nishitha Prabhu; Alsha Abdul Rahim; Anantha Naik Nagappa
Journal:  Saudi Pharm J       Date:  2016-07-30       Impact factor: 4.330

9.  Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control study.

Authors:  Vesna Šuljagić; Ivan Miljković; Srđan Starčević; Nenad Stepić; Zoran Kostić; Dragutin Jovanović; Jelena Brusić-Renaud; Biljana Mijović; Sandra Šipetić-Grujičić
Journal:  Antimicrob Resist Infect Control       Date:  2017-03-27       Impact factor: 4.887

10.  Prevention of nosocomial infections in critically ill patients with lactoferrin (PREVAIL study): study protocol for a randomized controlled trial.

Authors:  John Muscedere; David Maslove; John Gordon Boyd; Nicole O'Callaghan; Francois Lamontagne; Steven Reynolds; Martin Albert; Rick Hall; Danielle McGolrick; Xuran Jiang; Andrew G Day
Journal:  Trials       Date:  2016-09-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.